Concordance of human equilibrative nucleoside transporter‐1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trial

Concordance of human equilibrative nucleoside transporter‐1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trial

Abstract Background Expression of human equilibrative nucleoside transporter‐1 (hENT1) is reported to predict survival of gemcitabine (GEM)‐treated patients. However, predictive values of immunohistochemical hENT1 expression may differ according to the antibodies, 10D7G2 and SP120. Aim We aimed to i...

Full description

Bibliographic Details
Main Authors: Yukiyasu Okamura, Narikazu Boku, Paula Ghaneh, William Greenhalf, Satoru Yasukawa, Hiroto Narimatsu, Akira Fukutomi, Masaru Konishi, Soichiro Morinaga, Hirochika Toyama, Atsuyuki Maeda, Yasuhiro Shimizu, Shoji Nakamori, Naohiro Sata, Keisuke Yamakita, Amane Takahashi, Wataru Takayama, Ryuzo Yamaguchi, Moriaki Tomikawa, Akio Yanagisawa, John P. Neoptolemos, Katsuhiko Uesaka
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Cancer Reports
Subjects:
10D7G2
gemcitabine
human equilibrative nucleoside transporter‐1
pancreatic cancer
SP120
Online Access:https://doi.org/10.1002/cnr2.1507

Internet

https://doi.org/10.1002/cnr2.1507

Similar Items